Artikler
Real-World Evidence and Phase IV studies in CRSwNP
Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) generally have a high symptom burden and poor health-related quality of life (QoL), often requiring recurring systemic corticosteroid use and repeated sinus surgery.
DUPIREAL: Two-Year Turning Point with Dupilumab in CRSwNP
The results from the DUPIREAL real-world study reinforce the efficacy of dupilumab demonstrated in the SINUS-24 and SINUS-52 randomized clinical trials and are consistent with the approved SmPC.1,2,3,4 DUPIREAL is the largest long-term real-world study (n=926) evaluating the effectiveness of dupilumab, including treatment response, disease control and remission, in severe uncontrolled CRSwNP over 2 years.2,3
Efficacy and safety of dupilumab in patients with PN with or without a history of atopic comorbidities
FLUNITY-HD : the largest individually randomised influenza vaccine effectiveness study of its kind.
FLUNITY-HD is the largest individually randomised influenza vaccine effectiveness study, with nearly half a million older adults across multiple seasons.1
BRIGHT publication
The Bright study demonstrated similar efficacy and safety of Toujeo® (Glargine 300) compared to degludec (insulin degludec) in type 2 diabetes patients who had not previously received basal insulin1.
Utdannelse
Expert video: Complex type 2 inflammation, refreshingly simple
Professor Lipworth provides quick insight with the bucket model.
Oppdaterte behandlingskriterier for Dupixent ved CRSwNP
Overlege Jörg Törpel gir en oppdatering av nye behandlingskriterier for behandling med Dupixent hos personer med alvorlig kronisk rhinosinusitt med nasal polypose (CRSwNP).
FLUNITY-HD: Results of the pooled analysis of the two individually randomized real-world studies, DANFLU 2 and GALFLU
Monday September 15th, 2025 16:00-17:15 CET
A heart for Fabry - Podcast
A podcast series designed by cardiologists, for cardiologists and other healthcare professionals.
Podcasts
Polyp Gossip
Polyp Gossip is a video podcast dedicated to exploring Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Hosted by two globally recognized rhinologists. The show delves into trending topics, latest advancements, and patient experiences.
The Hematology Podcast
Welcome to The Hematology Podcast, your source for the latest insights into hematology and rare blood disorders. This podcast covers cutting-edge research, clinical advancements, and real-world cases tailored for healthcare professionals.
A heart for Fabry - Podcast
A podcast series designed by cardiologists, for cardiologists and other healthcare professionals.
DermTalks
Are you interested in learning more about managing atopic dermatitis in specific patient groups? Look no further and listen to the DermTalks Podcast - Atopic Dermatitis in Special Populations!
Hot topics in atopic dermatitis
This podcast episode highlights an engaging discussion on managing atopic dermatitis, featuring Dr. Andrew Pink, a consultant dermatologist from UK. Emmanuel Tony and Ashlyn Kerry guide the conversation. Dr. Pink discusses the challenges and strategies in treating eczema, emphasizing personalized treatment plans and the importance of patient communication.
RespTalks
Resptalks is a series of scientific webinars & podcasts on current topics related to respiratory diseases such as asthma, chronic rhinosinusitis with nasal polyps, to type 2 inflammation and much more. They are intended for pulmonologists, ENTs, allergologists, pediatricians, scientists from the Nordics countries and the BeNeLux.
Time in range
Denne episoden handler om Time in Range (TIR), som er et ganske nytt behandlingsprinsipp innenfor diabetes og som på norsk kalles ‘tid i målområdet’. Endokrinolog og overlege ved Stavanger Universitetssykehus Sondre Vatne Meling samtaler med podcastvert, lege og adferdsforsker Herman Escher Egenberg.
Treatable Traits & Asthma
A podcast about treatable traits in asthma with Professor Backer, Pavord and Gibson. This podcast is for healthcare professionals that are interested in being updated within asthma or interested in learning more about how to treat asthma patients in the most optimal way according to available science and clinical experiences.